QCM
HAE icon

Quantinno Capital Management’s Haemonetics HAE Stock Holding History

Quantinno Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.48M Buy
73,034
+42,326
+138% +$2.72M 0.01% 1233
2026
Q1 		$1.73M Buy
30,708
+25,000
+438% +$1.63M ﹤0.01% 1721
2025
Q4 		$457K Buy
5,708
+931
+19% +$62.6K ﹤0.01% 2512
2025
Q3 		$233K Buy
4,777
+1,285
+37% +$79.5K ﹤0.01% 2648
2025
Q2 		$261K Buy
3,492
+289
+9% +$19.1K ﹤0.01% 2137
2025
Q1 		$204K Buy
+3,203
New +$218K ﹤0.01% 1877

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's HAE Position: Q2 2026 in Review

Quantinno Capital Management increased its Haemonetics (HAE) stake by 138% in Q2 2026, buying an estimated $2.72M and bringing the position to 73,034 shares worth $5.48M. The position accounts for 0.01% of the portfolio, ranked #1233.

Quantinno Capital Management first reported a position in HAE in Q1 2025 and has held it in 6 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Quantinno Capital Management held 73,034 shares of Haemonetics worth $5.48M as of Q2 2026.
  • Quantinno Capital Management bought 42,326 Haemonetics shares in Q2 2026, an estimated $2.72M.
  • Haemonetics made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1233 holding.
  • Quantinno Capital Management first reported a position in Haemonetics in Q1 2025 and has held it in 6 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.